Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL))-Reference-Cited by-同舟云学术

Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL))

Published:2018-08-06 Issue:8 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Küley-Bagheri Yasemin¹,Kreuzer Karl-Anton²,Monsef Ina¹,Lübbert Michael³,Skoetz Nicole¹

Affiliation:

1. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Cologne Germany

2. University Hospital of Cologne; Department I of Internal Medicine; Cologne Germany

3. University Hospital of Freiburg; Freiburg Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011960.pub2/epdf/full

Reference80 articles.

1. Schlenk R Dohner K Krauter J Gaidzik VI Paschka P Heuser M All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia-final results of the AMLSG 07-04 randomized treatment trial Annals of Hematology 2014 222

2. Schlenk RF Doehner K Krauter J Gaidzik VI Paschka P Heuser M All-trans retinoic acid improves outcome in younger adult patients with nucleophosmin-1 mutated acute myeloid leukemia - results of the AMLSG 07-04 randomized treatment trial [abstract no. 80] Blood 2011

3. All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study;Schlenk;Annals of Hematology,2016

4. DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy;Grishina;BMC Cancer,2015

5. Lübbert M Grishina O Schmoor C Schlenk RF Jost E Krauter J Results of the randomized phase II study decider (AMLSG 14-09) comparing decitabine (DAC) with or without valproic acid (VPA) and with or without all-t ransr etinoic acid (ATRA) add-on in newly diagnosed elderly non-fit AML patients Blood 2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia;Frontiers in Pharmacology;2024-07-04

2. The CDK4/6 Inhibitor Palbociclib Synergizes with ATRA to Induce Differentiation in AML;Molecular Cancer Therapeutics;2024-03-20

3. Novel indole retinoid derivative induces apoptosis and cell cycle arrest and modulates AKT and ERK signaling in HL‐60 cells;Fundamental & Clinical Pharmacology;2023-01-30

4. All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity;PLOS ONE;2022-11-04

5. A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study;Chinese Medical Journal;2022-09-13